Long-acting injectable PrEP, known as CAB-LA, offers a powerful new option for HIV prevention. With proven clinical efficacy, a convenient 8-week dosing schedule, and expanding global availability, including in Thailand. It represents a major step forward in HIV prevention efforts. This article explores how it works, its safety profile, cost considerations, and what the future holds for injectable PrEP.

This is a quick guideline to understand more about HIV, treatment, and prevention

Blood test for STDs prevention and treatments: Protect Your Health with Essential Knowledge